IRT Early Phase Studies

Early Phase Studies

Today’s early phase studies are more complex, reflecting a growing trend towards personalized medicine and gene therapies, creative trial designs, expanded protocol complexity, and an increasing number of protocol amendments.

Traditional methods of using spreadsheets and manually tracking randomization and trial supply information and changes throughout can become cumbersome and error prone. Technology solutions for early phase studies are now even more important for protecting data integrity and minimizing risks to timelines.

Decipher, Standardize and Transform Your Processes

Robust, Simplified IRT Solution

YPrime offers a fully featured yet simplified IRT platform for early phase studies that is cost-effective and configurable, so that you can rapidly implement and realize the full benefits of this technology. Our IRT platform for early phase studies allows you to:

  • Configure randomization and supply parameters effortlessly, without the expense of customized system development.
  • Implement in less than four weeks with fixed delivery timelines.
  • Establish a reliable budget with this fixed-cost solution, which can be more affordable than using spreadsheets to manage and track the same information.
  • Maintain better quality control than paper-based studies to ensure data integrity.
  • Make changes quickly after go-live without additional programming or validation, minimizing risks to timelines.

Decipher the complexities of patient randomization and clinical supply management

See How YPrime’s IRT Solutions Help You Simplify, Standardize, and Transform Your Processes.


Fully Featured Yet Simplified Phase 1 IRT Solution


YPrime IRT Solutions


Overcoming Complex Challenges: Identifying eCOA and IRT Trends